Interaction of trivalent arsenicals with metallothionein

Chemical Research in Toxicology

Volumn 16, Issue 7, 2003, Pages 873-880

  Jiang, Guifeng ^a   Gong, Zhilong ^a   Li, Xing Fang ^a   Cullen, William R ^b   Le, X Chris ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; CARCINOGEN; DIMETHYLARSINOUS ACID; DRINKING WATER; METAL COMPLEX; METALLOTHIONEIN; MONOMETHYLARSONOUS ACID; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; BINDING AFFINITY; BLADDER CANCER; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CHEMICAL REACTION; COMPLEX FORMATION; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG CANCER; MASS SPECTROMETRY; SKIN CANCER; STOICHIOMETRY; WATER CONTAMINATION;

EID: 0041963073     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx034053g     Document Type: Article

References (62)

1. NRC (National Research Council) (1999) Arsenic in Drinking Water, National Academy Press, Washington, DC.
2. NRC (National Research Council) (2001) Arsenic in Drinking Water - Update, National Academy Press, Washington, DC.
3. Chen, C. J., Chuang, Y. C., Lin, T. M., and Wu, H. Y. (1985) Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan - high-arsenic artesian well water and cancers. Cancer Res. 45, 5895-5899.
4. Smith, A. H., Goycolea, M., Haque, R., and Biggs, M. L. (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147, 660-669.
5. Das, D., Chatterjee, A., Samanta, G., Mandal, B., Chowdhury, T. R., Chowdhury, P. P., Chanda, C., Basu, G., Lodh, D., Nandi, S., Chakraborty, T., Mandal, S., Bhattacharya, S. M., and Chakraborti, D. (1994) Arsenic contamination in groundwater in 6 districts of West Bengal, India - the biggest arsenic calamity in the world. Analyst 119, N168-N170.
6. Cebrian, M. E., Albores, A., Aguilar, M., and Blakely, E. (1983) Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol. 2, 121-133.
7. Bagla, P., and Kaiser, J. (1996) India's spreading health crisis draws global arsenic experts. Science 274, 174-175.
8. Chappell, W. R., Beck, B. D., Brown, K. G., Chaney, R., Cothern, C. R., Irgolic, K. J., North, D. W., Thornton, I., and Tsongas, T. A. (1997) Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ. Health Perspect. 105, 1060-1067.
9. Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B. D., Fowler, B. A., Goyer, R. A., Menzer, R., Rossman, T., Thompson, C., and Waalkes, M. (1999) Arsenic: health effects, mechanisms of actions, and research Issues. Environ. Health Perspect. 107, 593-597.
10. Rossman, T. G. (1998) Molecular and genetic toxicology of arsenic. In Environmental Toxicology: Current Developments (Rose, J., Ed.) pp 171-187, Gordon and Breach Science Publishers, Amsterdam.
11. Kitchin, K. T. (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
12. Hughes, M. F. (2002) Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133, 1-16.
13. Liu, S. X., Athar, M., Lippai, I., Waldren, C., and Hei, T. K. (2001) Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U.S.A. 98, 1643-1648.
14. Yamauchi, H., and Fowler, B. A. (1994) Toxicity and metabolism ofinorganic and methylated arsenicals. In Arsenic in the Environment, Part II: Human Health and Ecosystem Effects (Nriagu, J. O., Ed.) pp 35-43, Wiley, New York.
15. Cullen, W. R., and Reimer, K. J. (1989) Arsenic speciation in the environment. Chem. Rev. 89, 713-764.
16. Aposhian, H. V. (1997) Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37, 397-419.
17. Vahter, M. (1999) Variation in human metabolism of arsenic. In Arsenic Exposure and Health Effects (Chappell, W. R., Abernathy, C. O., and Calderon, R. L., Eds.) pp 267-279, Elsevier, Amsterdam.
18. Cullen, W. R., McBride, B. C., and Reglinski, J. (1984) The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals. J. Inorg. Biochem. 21, 45-60 and 179-194.
19. Buchet, J. P., and Lauwerys, R. (1994) Inorganic arsenic metabolism in humans. In Arsenic Exposure and Health (Chappell, W. R., Abernathy, C. O., and Cothern, C. R., Eds.) pp 181-189, Science and Technology Letters, Northwood, U.K.
20. Styblo, M., Delnomdedieu, M., and Thomas, D. J. (1995) Biological mechanisms and toxicological consequences of the methylation of arsenic. In Toxicology of Metals - Biochemical Aspects, Handbook of Experimental Pharmacology (Goyer, R. A., and Cherian, G., Eds.) pp 407-433, Springer-Verlag, Berlin.
21. Zakharyan, R. A., Wu, Y., Bogdan, G. M., and Aposhian, H. V. (1995) Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8, 1029-1038.
22. V) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14, 1051-1057.
23. Lin, S., Shi, Q., Nix, F. B., Styblo, M., Beck, M. A., Herbin-Davis, K. M., Hall, L. L., Simeonsson, J. B., and Thomas, D. J. (2002) A novel S-adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277, 10795-10803.
24. Goyer, R. A. (1996) Toxic effects of metals. In Casarett and Doull's Toxicology: The Basic Science of Poisons (Klaassen, C. D., Ed.) 5th ed., pp 696-698, McGraw-Hill, New York.
25. III) in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13, 693-697.
26. Le, X. C., Lu, X., Ma, M., Cullen, W. R., Aposhian, H. V., and Zheng, B. (2000) Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72, 5172-5177.
27. Le, X. C., Ma, M., Lu, X., Cullen, W. R., Aposhian, H. V., and Zheng, B. (2000) Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 108, 1015-1018.
28. Del Razo, L. M., Styblo, M., Cullen, W. R., and Thomas, D. J. (2001) Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174, 282-293.
29. Mandal, B. K., Ogra, Y., and Suzuki, K. T. (2001) Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14, 371-378.
30. Cohen, S. M., Arnold, L. L., Uzvolgyi, E., Cano, M., St. John, M., Yamamoto, S., Lu, X., and Le, X. C. (2002) Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15, 1150-1157.
31. Styblo, M., Serves, S. V., Cullen, W. R., and Thomas, D. J. (1997) Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10, 27-33.
32. Lin, S., Cullen, W. R., and Thomas, D. J. (1999) Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 12, 924-930.
33. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163, 203-207.
34. 50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14, 651-656.
35. Mass, M. J., Tennant, A., Roop, R. C., Cullen, W. R., Styblo, M., Thomas, D. J., and Kligerman, A. D. (2001) Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14, 355-361.
36. Bogdan, G. M., Sampayo-Reyes, A., and Aposhian, H. V. (1994) Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology 93, 175-193.
37. Styblo, M., and Thomas, D. J. (1997) Binding of arsenicals to proteins in an in vitro methylation system. Toxicol. Appl. Pharmacol. 147, 1-8.
38. Kreppel, H., Bauman, J. W., Liu, J., McKim, J. M., Jr., and Klaassen, C. D. (1993) Induction of metallothionein by arsenicals in mice. Fundam. Appl. Toxicol. 20, 184-189.
39. Hochadel, J. F., and Waalkes, M. (1997) Sequence of exposure to cadmium and arsenic determines the extent of toxic effects in male Fischer rats. Toxicology 116, 89-98.
40. Flora, S. J., and Tripathi, N. (1998) Hepatic and renal metallothionein induction following single oral administration of gallium arsenide in rats. Biochem. Mol. Biol. Int. 45, 1121-1127.
41. Falnoga, I., Stibilj, E., Tusek-Znidaric, M., Slejkovec, Z., Mazej, D., Jacimovic, R., and Scancar, J. (2000) Effect of arsenic trioxide on metallothionein and its conversion to different arsenic metabolites in hen liver. Biol. Trace Elem. Res. 78, 241-254.
42. Romach, E. H., Zhao, C. Q., Del Razo, L. M., Cebrian, M. E., and Waalkes, M. P. (2000) Studies on the mechanisms of arsenic-induced self-tolerance developed in liver epithelial cells through continuous low-level arsenite exposure. Toxicol. Sci. 54, 500-508.
43. Liu, J., Kadiiska, M. B., Liu, Y., Lu, T., Qu, W., and Waalkes, M. P. (2001) Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol. Sci. 61, 314-320.
44. Klaassen, C. D., Liu, J., and Choudhuri, S. (1999) Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu. Rev. Pharmacol. Toxicol. 39, 267-294.
45. Cullen, W. R., McBride, B. C., Manji, H., Pickett, A. W., and Reglinski, J. (1989) The metabolism of methylarsine oxide and sulfide. Appl. Organomet. Chem. 3, 71-78.
46. Burrows, G. J., and Turner, E. E. (1920) A new type of compound containing arsenic. J. Chem. Soc. Trans. 117, 1373-1383.
47. Le, X. C., and Ma, M. (1998) Short-column liquid chromatography with hydride generation atomic fluorescence detection for the speciation of arsenic. Anal. Chem. 70, 1926-1933.
48. Feldmann, J., Lai, V. W. M., Cullen, W. R., Ma, M., Lu, X., and Le, X. C. (1999) Sample preparation and storage can change arsenic speciation in human urine. Clin. Chem. 45, 1988-1997.
49. Chouchane, S., and Snow, E. T. (2001) In vitro effect of arsenical compounds oil glutathione-related enzymes. Chem. Res. Toxicol. 14, 517-522.
50. Toyama, M., Yamashita, M., Hirayama, N., and Murooka, Y. (2002) Interactions of arsenic with human metallothionein-2. J. Biochem. (Japan) 132, 217-221.
51. Muller, S., Walter, R. D., and Fairlamb, A. H. (1995) Differential susceptibility of filarial and human erythrocyte glutathione-reductase to inhibition by the trivalent organic arsenical melarsen oxide. Mol. Biochem. Parasitol. 71, 211-219.
52. Lin, S., Del Razo, L. M., Styblo, M., Wang, C. Q., Cullen, W. R., and Thomas, D. J. (2001) Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 14, 305-311.
53. Stevenson, K. J., Hale, G., and Perham, R. N. (1978) Inhibition of pyruvate-dehydrogenase multi-enzyme complex from Escherichia coli with monofunctional and bifunctional arsenoxides. Biochemistry 17, 2189-2192.
54. Bode, A. M., and Dong, Z. G. (2002) The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit. Rev. Oncol. Hematol. 42, 5-24.
55. Nordberg, M. (1998) Metallothioneins: historical review and state of knowledge. Talanta 43, 243-254.
56. Gong, Z., Lu, X., Cullen, W. R., and Le, X. C. (2001) Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 16, 1409-1413.
57. Margoshes, M., and Vallee, B. L. (1957) A cadmium protein from equine kidney cortex [Letter]. J. Am. Chem. Soc. 79, 4813-4814.
58. Stillman, M. J., Shaw, C. F., III, and Suzuki, K. T. (1992) Metallothioneins: Synthesis, Structure and Properties of Metallothioneins, Phytochelatins and Metal-Thiolate Complexes, VCH, New York.
59. Liu, J., Liu, Y., Goyer, R. A., Achanzar, W., and Waalkes, M. P. (2000) Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol. Sci. 55, 460-467.
60. Park, J. D., Liu, Y. P., and Klaassen, C. D. (2001) Protective effect of metallothionein against the toxicity of cadmium and other metals. Toxicology 163, 93-100.
61. Maitani, T., Saito, N., Mayumi, A., Uchiyama, S., and Saito, Y. (1987) Chemical form-dependent induction of hepatic zincthionein by arsenic administration and effect of co-adminstered selenium in mice. Toxicol. Lett. 39, 63-70.
62. Kreppel, H., Liu, J., Liu, Y., Reichl, F. X., and Klaassen, C. D. (1994) Zinc-induced arsenite tolerance in mice. Fundam. Appl. Toxicol. 23, 32-37.